Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Raltegravir switch improves hepatitis C transaminitis in HIV-1 and hepatitis C (HCV) co-infected individuals ; volume:9 ; number:1 ; day:25 ; month:5 ; year:2012 ; pages:1 ; date:12.2012
Retrovirology ; 9, Heft 1 (25.5.2012), 1, 12.2012
- Urheber
-
Cevik, Muge
- Beteiligte Personen und Organisationen
-
Singh, Gurmit
Dickinson, Laura
Scourfield, Andrew
Boffito, Marta
Nelson, Mark
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S1-O7
- URN
-
urn:nbn:de:1111-2016080723601
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cevik, Muge
- Singh, Gurmit
- Dickinson, Laura
- Scourfield, Andrew
- Boffito, Marta
- Nelson, Mark
- SpringerLink (Online service)
Ähnliche Objekte (12)
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH
Hepatitis B vaccine efficacy in HCV vertical infected infants
Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH
Hepatitis B vaccine efficacy in HCV vertical infected infants
Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected
Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
Hepatitis C treatment initiation in HIV-HCV coinfected patients
Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B
German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients
Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH
Hepatitis B vaccine efficacy in HCV vertical infected infants
Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected